Management of pediatric uveitis.

F1000Prime Rep

Massachusetts Eye Research and Surgery Institution (MERSI) 5 Cambridge Center, Cambridge, MA 02142 USA ; Ocular Immunology and Uveitis Foundation 348 Glen Road, Weston, MA 02493 USA ; Department of Ophthalmology, Harvard Medical School 25 Shattuck Street, Boston, MA 02115 USA.

Published: July 2014

Pediatric uveitis is a topic of special interest not only because of the unique diagnostic and therapeutic challenges but also because of the lifetime burden of vision loss if the problem is not adequately treated, as well as the economic and psychological toll on the family. Often, uveitis in children is discovered as part of a routine eye exam; this silent, insidious inflammation can be difficult to treat and can lead to further complications if not handled skillfully. Corticosteroids have long been the mainstay of therapy; however, the significant associated side effects mandate a corticosteroid-sparing therapeutic regimen in pursuit of remission. In this review, we cover the therapeutic options for pediatric uveitis, specifically focusing on the most common non-infectious varieties, juvenile idiopathic arthritis-associated uveitis and pars planitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047950PMC
http://dx.doi.org/10.12703/P6-41DOI Listing

Publication Analysis

Top Keywords

pediatric uveitis
12
uveitis
5
management pediatric
4
uveitis pediatric
4
uveitis topic
4
topic special
4
special interest
4
interest unique
4
unique diagnostic
4
diagnostic therapeutic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!